Global X S&P Biotech ETF
CURE
- A$78.58
- 0.82
- 1.06%
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Young & Invested: The one ETF portfolio
99% of investors won’t be the next Warren Buffett – luckily, we don’t need that to be successful.
etfs
3 top rated fixed interest ETFs
Investors are pouring money into fixed interest ETFs – here are our top picks.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,198.30 | 37.90 | 0.41% |
| CAC 40 | 8,268.82 | 11.81 | -0.14% |
| DAX 40 | 25,976.58 | 137.25 | 0.53% |
| Dow JONES (US) | 53,441.93 | 379.98 | 0.72% |
| FTSE 100 | 10,817.52 | 61.07 | 0.57% |
| HKSE | 25,213.31 | 97.90 | -0.39% |
| NASDAQ | 26,467.46 | 249.63 | 0.95% |
| Nikkei 225 | 64,214.48 | 111.16 | -0.17% |
| NZX 50 Index | 13,846.18 | 84.39 | -0.61% |
| S&P 500 | 7,713.04 | 46.44 | 0.61% |
| S&P/ASX 200 | 9,020.10 | 46.10 | 0.51% |
| SSE Composite Index | 3,942.09 | 0.70 | 0.02% |